Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: A retrospective case series

Clinical Infectious Diseases

Volumn 56, Issue 11, 2013, Pages 1573-1578

  Levy, Emily R ^a   McCarty, James M ^b,c   Shane, Andi L ^d   Weintrub, Peggy S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

caspofungin; coccidioidomycosis; pediatrics; refractory; voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; TRIAZOLE; VORICONAZOLE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COCCIDIOIDOMYCOSIS; DRUG TREATMENT FAILURE; FEMALE; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION;

CASPOFUNGIN; COCCIDIOIDOMYCOSIS; PEDIATRICS; REFRACTORY; VORICONAZOLE;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; COCCIDIOIDOMYCOSIS; ECHINOCANDINS; FEMALE; HUMANS; INFANT; MALE; PYRIMIDINES; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; TRIAZOLES;

EID: 84877251377     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit113     Document Type: Article

References (28)

1. Hector RF, Rutherford GW, Tsang CA, et al. The public health impact of coccidioidomycosis in Arizona and California. Int J Environ Res Public Health 2011; 8:1150-73.
2. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41:1217-23.
3. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral flucona-zole and itraconazole for progressive, nonmeningeal coccidioidomyco-sis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med 2000; 133:676-8.
4. Tucker RM, Denning DW, Arathoon EG, Rinaldi MG, Stevens DA. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 1990; 23(3 Pt 2): 593-601.
5. Diaz M, Negroni R, Montero-Gei F, et al. A pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. Clin Infect Dis 1992; 14(suppl 1):S68-76.
6. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med 1993; 119:28-35.
7. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioi-domycosis. NIAID Mycoses Study Group. Am J Med 1995; 98:249-56.
8. Deresinski SC. Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis 2001; 14:693-6.
9. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis 2004; 39:e74-7.
10. Proia LA, Tenorio AR. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother 2004; 48:2341.
11. Kim MM, Vikram HR, Kusne S, Seville MT, Blair JE. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis 2011; 53:1060-6.
12. Gonzalez GM, Tijerina R, Najvar LK, et al. Correlation between anti-fungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother 2001; 45:1854-9.
13. Cordeiro RA, Brilhante RS, Rocha MF, et al. In vitro activities of caspo-fungin, amphotericin B and azoles against Coccidioides posadasii strains from northeast, Brazil. Mycopathologia 2006; 161:21-6.
14. Park DW, Sohn JW, Cheong HJ, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis 2006; 6:26.
15. Antony S. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 2004; 39:879-80.
16. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemo-ther 2004; 54:292-4.
17. Gonzalez GM, Gonzalez G, Najvar LK, Graybill JR. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxy-cholate for coccidioidomycosis in a mouse model. J Antimicrob Che-mother 2007; 60:1341-6.
18. Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002; 46:2564-8.
19. Kontoyiannis DP, Lewis RE. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist Updat 2003; 6:257-69.
20. Kontoyiannis DP, Ratanatharathorn V, Young JA, et al. Micafungin alone or in combination with other systemic antifungal therapies in he-matopoietic stem cell transplant recipients with invasive aspergillosis. Transpl Infect Dis 2009; 11:89-93.
21. Thomas A, Korb V, Guillemain R, et al. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. J Clin Pharm Ther 2010; 35:49-53.
22. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003; 187:1834-43.
23. Shane AL, Weintrub PS. Voriconazole and caspofungin combination therapy for disseminated coccidioidomycosis in children. In: 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, 6 October 2005. Abstract 586.
24. Ampel NM. Coccidioidomycosis: a review of recent advances. Clin Chest Med 2009; 30:241-51, v.
25. Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009; 53:1648-51.
26. Cao C, Liu W, Li R, Wan Z, Qiao J. In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei. J Antimicrob Chemother 2009; 63:340-2.
27. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996; 124:305-10.
28. Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 2003; 37(suppl 3):S188-224.